Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 254

1.

Transcriptional regulation of the mdm2 oncogene by p53 requires TRRAP acetyltransferase complexes.

Ard PG, Chatterjee C, Kunjibettu S, Adside LR, Gralinski LE, McMahon SB.

Mol Cell Biol. 2002 Aug;22(16):5650-61.

2.

A possible role of p73 on the modulation of p53 level through MDM2.

Wang XQ, Ongkeko WM, Lau AW, Leung KM, Poon RY.

Cancer Res. 2001 Feb 15;61(4):1598-603.

3.

SMAR1 forms a ternary complex with p53-MDM2 and negatively regulates p53-mediated transcription.

Pavithra L, Mukherjee S, Sreenath K, Kar S, Sakaguchi K, Roy S, Chattopadhyay S.

J Mol Biol. 2009 May 15;388(4):691-702. doi: 10.1016/j.jmb.2009.03.033. Epub 2009 Mar 19.

PMID:
19303885
4.

MDM2 suppresses p73 function without promoting p73 degradation.

Zeng X, Chen L, Jost CA, Maya R, Keller D, Wang X, Kaelin WG Jr, Oren M, Chen J, Lu H.

Mol Cell Biol. 1999 May;19(5):3257-66.

5.

MDM2 inhibits p300-mediated p53 acetylation and activation by forming a ternary complex with the two proteins.

Kobet E, Zeng X, Zhu Y, Keller D, Lu H.

Proc Natl Acad Sci U S A. 2000 Nov 7;97(23):12547-52.

6.
7.

E2F transcriptional activation requires TRRAP and GCN5 cofactors.

Lang SE, McMahon SB, Cole MD, Hearing P.

J Biol Chem. 2001 Aug 31;276(35):32627-34. Epub 2001 Jun 19.

8.

Acetylation of p53 activates transcription through recruitment of coactivators/histone acetyltransferases.

Barlev NA, Liu L, Chehab NH, Mansfield K, Harris KG, Halazonetis TD, Berger SL.

Mol Cell. 2001 Dec;8(6):1243-54.

9.

The kinetics of p53-binding and histone acetylation at target promoters do not strictly correlate with gene expression after UV damage.

Magrini R, Russo D, Fronza G, Inga A, Menichini P.

J Cell Biochem. 2007 Apr 1;100(5):1276-87.

PMID:
17063487
10.

MDM2 interaction with nuclear corepressor KAP1 contributes to p53 inactivation.

Wang C, Ivanov A, Chen L, Fredericks WJ, Seto E, Rauscher FJ 3rd, Chen J.

EMBO J. 2005 Sep 21;24(18):3279-90. Epub 2005 Aug 18.

11.

Mdm2 promotes the rapid degradation of p53.

Haupt Y, Maya R, Kazaz A, Oren M.

Nature. 1997 May 15;387(6630):296-9.

PMID:
9153395
12.

Ets1 is required for p53 transcriptional activity in UV-induced apoptosis in embryonic stem cells.

Xu D, Wilson TJ, Chan D, De Luca E, Zhou J, Hertzog PJ, Kola I.

EMBO J. 2002 Aug 1;21(15):4081-93.

13.

An N-terminal p14ARF peptide blocks Mdm2-dependent ubiquitination in vitro and can activate p53 in vivo.

Midgley CA, Desterro JM, Saville MK, Howard S, Sparks A, Hay RT, Lane DP.

Oncogene. 2000 May 4;19(19):2312-23.

14.

Mdm2 inhibition of p53 induces E2F1 transactivation via p21.

Wunderlich M, Berberich SJ.

Oncogene. 2002 Jun 27;21(28):4414-21.

15.
16.

YY1 inhibits the activation of the p53 tumor suppressor in response to genotoxic stress.

Grönroos E, Terentiev AA, Punga T, Ericsson J.

Proc Natl Acad Sci U S A. 2004 Aug 17;101(33):12165-70. Epub 2004 Aug 4.

17.
18.
19.

Regulation of the mdm2 oncogene by thyroid hormone receptor.

Qi JS, Yuan Y, Desai-Yajnik V, Samuels HH.

Mol Cell Biol. 1999 Jan;19(1):864-72.

20.

MDM2 inhibits PCAF (p300/CREB-binding protein-associated factor)-mediated p53 acetylation.

Jin Y, Zeng SX, Dai MS, Yang XJ, Lu H.

J Biol Chem. 2002 Aug 23;277(34):30838-43. Epub 2002 Jun 14.

Supplemental Content

Support Center